Engineering and characterisation of chimeric monoclonal antibody 806 (ch806) for targeted immunotherapy of tumours expressing de2-7 EGFR or amplified EGFR (Q36616502)

From Wikidata
Jump to navigation Jump to search
scientific article published on March 2005
edit
Language Label Description Also known as
English
Engineering and characterisation of chimeric monoclonal antibody 806 (ch806) for targeted immunotherapy of tumours expressing de2-7 EGFR or amplified EGFR
scientific article published on March 2005

    Statements

    Engineering and characterisation of chimeric monoclonal antibody 806 (ch806) for targeted immunotherapy of tumours expressing de2-7 EGFR or amplified EGFR (English)
    C Panousis
    V M Rayzman
    T G Johns
    C Renner
    G Cartwright
    F-T Lee
    A Kypridis
    F E Smyth
    M W Brechbiel
    A W Burgess
    A M Scott
    1 March 2005
    1069-1077

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit